BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37517694)

  • 1. A detailed kinetic model of glycolysis in Plasmodium falciparum-infected red blood cells for antimalarial drug target identification.
    van Niekerk DD; du Toit F; Green K; Palm D; Snoep JL
    J Biol Chem; 2023 Sep; 299(9):105111. PubMed ID: 37517694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of drug effects at the whole-body level: a case study for glucose metabolism in malaria patients.
    Snoep JL; Green K; Eicher J; Palm DC; Penkler G; du Toit F; Walters N; Burger R; Westerhoff HV; van Niekerk DD
    Biochem Soc Trans; 2015 Dec; 43(6):1157-63. PubMed ID: 26614654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico multiple-targets identification for heme detoxification in the human malaria parasite Plasmodium falciparum.
    Phaiphinit S; Pattaradilokrat S; Lursinsap C; Plaimas K
    Infect Genet Evol; 2016 Jan; 37():237-44. PubMed ID: 26626103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dramatic Consequences of Reducing Erythrocyte Membrane Cholesterol on Plasmodium falciparum.
    Ahiya AI; Bhatnagar S; Morrisey JM; Beck JR; Vaidya AB
    Microbiol Spectr; 2022 Feb; 10(1):e0015822. PubMed ID: 35196803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of Plasmodium falciparum-infected erythrocytes with chloroquine leads to accumulation of ferriprotoporphyrin IX bound to particular parasite proteins and to the inhibition of the parasite's 6-phosphogluconate dehydrogenase.
    Famin O; Ginsburg H
    Parasite; 2003 Mar; 10(1):39-50. PubMed ID: 12669348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Metabolite Repair Enzyme Phosphoglycolate Phosphatase Regulates Central Carbon Metabolism and Fosmidomycin Sensitivity in Plasmodium falciparum.
    Dumont L; Richardson MB; van der Peet P; Marapana DS; Triglia T; Dixon MWA; Cowman AF; Williams SJ; Tilley L; McConville MJ; Cobbold SA
    mBio; 2019 Dec; 10(6):. PubMed ID: 31822583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into host-parasite ubiquitin proteome dynamics in P. falciparum infected red blood cells using a TUBEs-MS approach.
    Mata-Cantero L; Azkargorta M; Aillet F; Xolalpa W; LaFuente MJ; Elortza F; Carvalho AS; Martin-Plaza J; Matthiesen R; Rodriguez MS
    J Proteomics; 2016 Apr; 139():45-59. PubMed ID: 26972027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Of membranes and malaria: phospholipid asymmetry in Plasmodium falciparum-infected red blood cells.
    Fraser M; Matuschewski K; Maier AG
    Cell Mol Life Sci; 2021 May; 78(10):4545-4561. PubMed ID: 33713154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting ion channels of Plasmodium falciparum-infected human erythrocytes for antimalarial development.
    Desai SA
    Curr Drug Targets Infect Disord; 2004 Mar; 4(1):79-86. PubMed ID: 15032636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized feasibility trial comparing four antimalarial drug regimens to induce
    Reuling IJ; van de Schans LA; Coffeng LE; Lanke K; Meerstein-Kessel L; Graumans W; van Gemert GJ; Teelen K; Siebelink-Stoter R; van de Vegte-Bolmer M; de Mast Q; van der Ven AJ; Ivinson K; Hermsen CC; de Vlas S; Bradley J; Collins KA; Ockenhouse CF; McCarthy J; Sauerwein RW; Bousema T
    Elife; 2018 Feb; 7():. PubMed ID: 29482720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
    Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
    Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial metabolism of sexual and asexual blood stages of the malaria parasite Plasmodium falciparum.
    MacRae JI; Dixon MW; Dearnley MK; Chua HH; Chambers JM; Kenny S; Bottova I; Tilley L; McConville MJ
    BMC Biol; 2013 Jun; 11():67. PubMed ID: 23763941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium falciparum utilizes pyrophosphate to fuel an essential proton pump in the ring stage and the transition to trophozoite stage.
    Solebo O; Ling L; Nwankwo I; Zhou J; Fu TM; Ke H
    PLoS Pathog; 2023 Dec; 19(12):e1011818. PubMed ID: 38048362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Malaria Parasite's Lactate Transporter PfFNT Is the Target of Antiplasmodial Compounds Identified in Whole Cell Phenotypic Screens.
    Hapuarachchi SV; Cobbold SA; Shafik SH; Dennis AS; McConville MJ; Martin RE; Kirk K; Lehane AM
    PLoS Pathog; 2017 Feb; 13(2):e1006180. PubMed ID: 28178359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efflux of 6-deoxy-D-glucose from Plasmodium falciparum-infected erythrocytes via two saturable carriers.
    Goodyer ID; Hayes DJ; Eisenthal R
    Mol Biochem Parasitol; 1997 Feb; 84(2):229-39. PubMed ID: 9084042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of action of quinoline antimalarial drugs in red blood cells infected by
    Kapishnikov S; Staalsø T; Yang Y; Lee J; Pérez-Berná AJ; Pereiro E; Yang Y; Werner S; Guttmann P; Leiserowitz L; Als-Nielsen J
    Proc Natl Acad Sci U S A; 2019 Nov; 116(46):22946-22952. PubMed ID: 31659055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transport proteins as drug targets in Plasmodium falciparum. New perspectives in the treatment of malaria].
    Ellekvist P; Colding H
    Ugeskr Laeger; 2006 Mar; 168(13):1314-7. PubMed ID: 16579884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Medicines for Malaria Venture Malaria Box contains inhibitors of protein secretion in Plasmodium falciparum blood stage parasites.
    Looker O; Dans MG; Bullen HE; Sleebs BE; Crabb BS; Gilson PR
    Traffic; 2022 Sep; 23(9):442-461. PubMed ID: 36040075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Plasmodium falciparum-infected red blood cell.
    Tilley L; Dixon MW; Kirk K
    Int J Biochem Cell Biol; 2011 Jun; 43(6):839-42. PubMed ID: 21458590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.